ANN-KRISTIN SWAHN: Open Payments
NPI 1710545603 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 51 payments from 20 companies in 2025. Trend: 2023 $861 · 2024 $1,011 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| PFIZER INC. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $32 |
| HARMONY BIOSCIENCES LLC | 2 | $32 |
Products named: BOTOX, CAPLYTA, JARDIANCE, VRAYLAR, NURTEC ODT, Sunosi, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across UT — which companies pay providers there.
